• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; REPLACEMENT HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; REPLACEMENT HEART VALVE Back to Search Results
Model Number 11500A19
Device Problems Positioning Problem (3009); Insufficient Information (3190)
Patient Problems Obstruction/Occlusion (2422); No Information (3190)
Event Date 09/12/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device evaluation is anticipated but has not yet begun.A supplemental report will be submitted upon completion.
 
Event Description
It was reported that a 19mm aortic valve was explanted at implant due to coronary obstruction.A 21mm pericardial aortic valve was implanted successfully.The patient was reported to be stable.As reported, the procedure started as a rat approach.Post-implant tee images were unsatisfactory, and indicative of poor perfusion of the heart.The decision was made to reopen the aorta.Through rat incision which was very small, the surgeon could not see the right coronary ostium.Patient was converted to full sternotomy to allow further investigation.Surgeon still could not see right coronary ostium, and removed the 19mm valve.When surgeon was able to see coronaries, he stated they seemed "off centered".Surgeon re-implanted the 19mm valve with slight reorientation.Once the valve was re-seated, surgeon still could not visualize right coronary ostium.To correct the anatomy, and also due to the patient's bsa, a decision was made to perform a root enlargement and the 19mm valve was explanted.
 
Manufacturer Narrative
X-ray demonstrated wireform intact, however distorted near commissure 1.Suture holes were visible around the sewing ring.The wireform was exposed on commissure 1.Partial or total occlusion or obstruction of the coronary ostia is a recognized complication of an aortic valve replacement and, less frequently, from mitral valve replacement.It is typically the result of a technical error during valve implant and not related to a product malfunction.However, partial or total occlusion of the ostia, if unrecognized, can result in angina, myocardial infarction, acute peri-operative right, left or bi-ventricular dysfunction and/or death.In this case the rat incision was converted to full sternotomy due to obstruction.Based on the product evaluation, the customer report of "coronary obstruction" could not be confirmed through visual observations.The root cause of the event remains indeterminable but was likely due to procedural factors.The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.There was no indication or allegation of a device malfunction contributing to the event.The ifu has been reviewed and no inadequacies have been identified with regards to warnings, contraindications, and the directions/conditions for the successful use of the device.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
REPLACEMENT HEART VALVE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key7935094
MDR Text Key122799351
Report Number2015691-2018-04046
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup,Followup
Report Date 09/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/04/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/13/2019
Device Model Number11500A19
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/03/2018
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age54 YR
-
-